Facial Nerve Disorders

Clinical Presentation

• Bell's Palsy may include symptoms such as tinnitus, hearing loss, and taste disturbances, affecting the entire distribution of the facial nerve (CN VII), as noted by the American College of Radiology 1
• Trigeminal neuralgia is characterized by brief, electric shock-like, paroxysmal painful attacks that occur in the distribution of a cranial or cervical nerve, resulting from injury or dysfunction of the peripheral or central nervous system, with presentation including sharp, shooting, burning, or electric shock-like pain, as reported by 2
• Neuralgic pain stems from neural pathway dysfunction rather than ongoing tissue injury, with distinct features that differentiate it from other pain types, including brief, paroxysmal episodes lasting seconds to minutes, and often provoked by innocuous stimuli, as noted by 2

Diagnostic Imaging

• The American College of Radiology recommends diagnostic imaging, specifically contrast-enhanced MRI, to rule out secondary causes of trigeminal neuralgia, with a high strength of evidence supporting its use 1, 3, 4
• MRI should cover the entire course of the trigeminal nerve to evaluate for causative lesions, and MR angiography is helpful to assess for neurovascular compression, as recommended by the American College of Radiology 3, 1, 4
• The following imaging modalities are used for diagnostic evaluation:

• Imaging should cover potential involvement of other cranial nerves and brainstem structures, and it is essential to rule out secondary causes, including multiple sclerosis, tumors affecting multiple cranial nerves, vascular abnormalities, and inflammatory conditions, as recommended by the American College of Radiology 1, 3

Treatment Options

• Anticonvulsants, such as carbamazepine and oxcarbazepine, are first-line treatments for trigeminal neuralgia, with gabapentin and pregabalin used for postherpetic neuralgia and diabetic neuropathic pain, with a high strength of evidence supporting their use, as recommended by the American Academy of Neurology 2, 5, 6, 7
• The target dose of carbamazepine is 400-800 mg daily divided in 2-3 doses, with a maximum dose not exceeding 1200 mg daily, and oxcarbazepine is a suitable alternative to carbamazepine, with similar efficacy and fewer side effects, as reported by 5, 7, 8, 6
• Gabapentin (300-3600 mg/day) and Pregabalin (150-600 mg/day) are second-line options for trigeminal neuralgia management, with the American Geriatrics Society recommending starting doses of pregabalin 25-50 mg/day or gabapentin 100-200 mg/day for older adults, as noted by 8, 9
• Tricyclic antidepressants are effective for neuropathic pain, according to the American College of Physicians, with a moderate strength of evidence, and the American Geriatrics Society recommends lower starting doses of 100 mg twice daily with more gradual titration for older adults, as reported by 10, 9
• Microvascular decompression (MVD) is optimal for patients with identifiable neurovascular compression, with 70% remaining pain-free at 10 years, according to the American Association of Neurological Surgeons, with a high strength of evidence supporting its use, and risks including 0.2-0.4% mortality and 1-4% hearing loss, as noted by 2, 4
• Stereotactic radiosurgery (Gamma Knife) achieves complete pain relief initially in 75% of patients, with 50% maintaining relief at 3 years, with a moderate strength of evidence supporting its use, and pain relief typically occurs within three months, although sensory disturbance is the most frequent complication, as reported by 2, 6
• Radiofrequency lesioning is appropriate for patients with trigeminal neuralgia when pain persists despite adequate medication trials, quality of life is significantly impacted, and prior surgical intervention has not provided complete relief, as noted by 4

Monitoring and Follow-up

• Regular monitoring of blood counts, sodium levels, and liver function is essential, especially during dose adjustments, to prevent hyponatremia and other adverse effects, as recommended by the American Academy of Neurology, and medical management with adequate dosing should be optimized before considering surgical options, as reported by 5, 4, 9, 6
• Ensuring trigeminal neuralgia symptoms remain well-controlled is critical when adjusting medications or considering surgical intervention, and an ENT consultation is appropriate if pain persists despite adequate carbamazepine dosing, or if there is suspicion of an underlying structural abnormality, as noted by 5, 6
• Obtain screening electrocardiogram for patients older than 40 years, especially with cardiac history, as recommended by the Mayo Clinic Proceedings, and a therapeutic plasma concentration of 24-43 μmol/L (4-8 mcg/mL) is recommended, as reported by 11, 12